Page last updated: 2024-08-23

levormeloxifene and Uterine Prolapse

levormeloxifene has been researched along with Uterine Prolapse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christiansen, C; Christoffersen, C; Delmas, PD; Riis, BJ; Stakkestad, JA; Warming, L	1

Trials

1 trial(s) available for levormeloxifene and Uterine Prolapse

Article	Year
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal. Maturitas, 2003, Mar-28, Volume: 44, Issue:3 Topics: Bone Density; Double-Blind Method; Endometrium; Female; Follow-Up Studies; Humans; Middle Aged; Pyrrolidines; Receptors, Estrogen; Safety; Selective Estrogen Receptor Modulators; Substance Withdrawal Syndrome; Time Factors; Urinary Incontinence; Uterine Prolapse	2003

Article

Year

Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.

Maturitas, 2003, Mar-28, Volume: 44, Issue:3

Topics: Bone Density; Double-Blind Method; Endometrium; Female; Follow-Up Studies; Humans; Middle Aged; Pyrrolidines; Receptors, Estrogen; Safety; Selective Estrogen Receptor Modulators; Substance Withdrawal Syndrome; Time Factors; Urinary Incontinence; Uterine Prolapse

2003